Rani Therapeutics Holdings (RANI) Payables (2020 - 2025)
Historic Payables for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to $2.5 million.
- Rani Therapeutics Holdings' Payables rose 5753.51% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 5753.51%. This contributed to the annual value of $1.4 million for FY2024, which is 10972.22% up from last year.
- Per Rani Therapeutics Holdings' latest filing, its Payables stood at $2.5 million for Q3 2025, which was up 5753.51% from $1.8 million recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Payables registered a high of $2.5 million during Q3 2025, and its lowest value of $506000.0 during Q2 2024.
- In the last 5 years, Rani Therapeutics Holdings' Payables had a median value of $1.4 million in 2022 and averaged $1.4 million.
- As far as peak fluctuations go, Rani Therapeutics Holdings' Payables plummeted by 5561.64% in 2023, and later skyrocketed by 25533.6% in 2025.
- Quarter analysis of 5 years shows Rani Therapeutics Holdings' Payables stood at $1.1 million in 2021, then skyrocketed by 35.19% to $1.5 million in 2022, then plummeted by 55.62% to $648000.0 in 2023, then soared by 109.72% to $1.4 million in 2024, then surged by 81.53% to $2.5 million in 2025.
- Its Payables was $2.5 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.5 million in Q1 2025.